The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)-a sector of the government agency that aims to incentivize innovation among providers and payers.
The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)—a sector of the government agency that aims to incentivize innovation among providers and payers.
States across the country have benefited from CMMI’s 10-year, $10 billion budget. In fact, it is the largest sum of funding ever devoted to healthcare transformation. The center intends to accelerate the development and testing of new payment and service delivery models at various healthcare organizations. The center’s supported innovation models are divided into 7 categories:
The group also encourages healthcare organizations and leaders to offer their own ideas about innovations. The center says it seeks input on innovative service delivery models, reimbursement models, and even technology.
“We look for ideas across the healthcare delivery continuum that achieve better care for patients, better health for our communities, and lower costs through improvement for our healthcare system,” the center said.
Still, not everyone is completely convinced that the group is fulfilling its purpose. “This is absolutely necessary” to try to change how care is bought and delivered, said Christopher Koller, president of the Milbank Memorial Fund, a nonprofit that works to improve medical decision making. “Is this the right way to do it? A whole bunch of experiments? Is the innovation center adequately resourced in an administrative way to do this? The jury is still out on this.”
CMMI programs focus on patient populations with expensive conditions including cancer, diabetes, and heart failure. Groups who opt into CMMI innovation programs must demonstrate quality improvements within 6 months of enrollment. Center officials maintain that the group has an important role in improving patients’ health and controlling the rising costs of healthcare throughout the country.
“We take the direction of Congress—that the goal was to test these models, to expand the successful ones, but also to terminate unsuccessful ones—very seriously,” said Patrick Conway, MD, who runs the center.
Around the Web
CMS is on a $10B Search for the Next Big Health Insurance Innovation — But Is It Going Anywhere? [MedCity News]
Innovation Models [CMS - CMMI]
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More